Navigation Links
DrugRisk Adds Study Showing Pradaxa May Increase Viral Infection Risk
Date:4/3/2013

Denver, CO (PRWEB) April 03, 2013

The prescription drug safety advocates at DrugRisk.com are alerting patients of new information on the site for those taking the blood thinner Pradaxa. A new study from The University of North Carolina suggests the atrial fibrillation drug may increase the chances of contracting some viral infections****.

DrugRisk was created to improve the safety of those taking prescription drugs by sharing the latest warnings, recalls, studies and legal news. Patients can see if others are experiencing similar side effects and decide if they need legal advice.

Experts have disagreed over whether Pradaxa, launched in 2010 to prevent strokes in patients with atrial fibrillation, causes higher risks of internal bleeding. The FDA recently advised that Pradaxa is no more dangerous than traditional blood thinner warfarin*.

The Institute for Safe Medication Practices, however, ranked blood thinners like Pradaxa among the most dangerous drugs, and warned that patients suffering Pradaxa bleeding are almost 5 times as likely to die than those with bleeding from warfarin**. Researchers with the University of Illinois at Chicago also recently warned that the data used by the FDA may be flawed, and the risk for bleeding from Pradaxa may be higher than previously thought***.

Now, DrugRisk has learned of a new study by researchers at the University of North Carolina, which suggests the blood-thinning properties of Pradaxa may make patients more susceptible to certain viral infections****. By reducing the innate properties of thrombosis, users may become more prone to flu and myocarditis****.

Already, more than 260 patients have filed a Pradaxa lawsuit over allegations of internal bleeding, which have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

Anyone affected by alleged Pradaxa internal bleeding after taking the drug is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Pradaxa lawsuits.

For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
**Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
***http://www.dailyrx.com/dabigatran-prevent-stroke-and-blood-clots-may-cause-excess-bleeding-reports-are-conflicting
****http://www.sciencedaily.com/releases/2013/04/130401132058.htm

Read the full story at http://www.prweb.com/releases/pradaxa-internal-bleeding/lawsuit-recall/prweb10594448.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
2. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
3. DrugRisk Announces Updated Information on Mirena Lawsuits
4. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
5. DrugRisk Announces New Pradaxa Health Warning From Australia
6. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
7. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
8. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
9. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
10. DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
11. DrugRisk Update: Evidence Submitted in Actos Lawsuit Suggests Drug Maker Knew of Cancer Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... Spain (PRWEB) , ... April 24, 2017 , ... ... on the development of next generation neuro-thrombectomy systems for the treatment of Acute ... and manufacture its ANCD BRAIN device as the product advances towards regulatory and ...
(Date:4/23/2017)... ... 2017 , ... "An event Horizon is a place where the laws of ... and Music. These are created as Metaphysical Transformations where music, which is the origin ... the ultimate singularity.", -- Karen Salicath Jamali , Karen will also preview her upcoming ...
(Date:4/22/2017)... ... ... Ecommerce sales have grown every year since the 1990’s, with 2016 retail ... of rapid innovation and growth are often neglected in the name of progress. As ... individual’s job to give something back to the planet that provides the resources needed ...
(Date:4/22/2017)... White Plains, NY (PRWEB) , ... April 22, ... ... Quarterly Report, which shows that U.S. consumers can save an average of 70% ... Even greater savings (up to 97%) are available when purchasing from other countries. ...
(Date:4/22/2017)... Capistrano (PRWEB) , ... April 22, 2017 , ... The San Juan Capistrano summer ... released a parenting report outlining the need for summer camps to provide physical activities for ... Importance of Physical Activity In Summer Camps , With an increase in specialty camps that ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
(Date:4/18/2017)... April 18, 2017 Cogentix Medical, Inc. (NASDAQ: ... the Urology, Uro/Gyn and Gynecology markets with innovative and ... quarter ended March 31, 2017 after the market close ... Company will host a conference call and webcast to ... May 2, 2017 at 4:30 p.m. Eastern Time (3:30 ...
Breaking Medicine Technology: